Global cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2015 | 20.7K |
Cancer statistics, 2015 | Ca-A Cancer Journal for Clinicians | 2015 | 10.2K |
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 | Annals of Oncology | 2015 | 1.4K |
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report | Biology of Blood and Marrow Transplantation | 2015 | 1.2K |
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 | Annals of Oncology | 2015 | 1.1K |
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes | Blood | 2015 | 1K |
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2015 | 962 |
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies | Annals of Oncology | 2015 | 828 |
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts | Blood | 2015 | 693 |
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2015 | 658 |
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases | Cytokine | 2015 | 547 |
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib | Blood | 2015 | 529 |
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | 2015 | 528 |
Oral cavity and oropharyngeal squamous cell carcinoma--an update | Ca-A Cancer Journal for Clinicians | 2015 | 512 |
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations | Blood | 2015 | 497 |
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study | Annals of Oncology | 2015 | 480 |
Exosomes in cancer: small particle, big player | Journal of Hematology and Oncology | 2015 | 475 |
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer | International Journal of Clinical Oncology | 2015 | 467 |
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia | Blood | 2015 | 457 |
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) | Annals of Oncology | 2015 | 451 |
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma | Radiotherapy and Oncology | 2015 | 444 |
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia | Blood | 2015 | 431 |
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report | Blood | 2015 | 426 |
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations† | Annals of Oncology | 2015 | 424 |
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease | Biology of Blood and Marrow Transplantation | 2015 | 415 |